NYSE$BHVN

Biohaven Ltd old · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Headline financials

Total Revenue

$190M

Previous: $35.1M+441.1%
EPS (adj)

-$2.32

Previous: -$2.69+13.8%
Capital Expenditures

$201K

Previous: $1.1M-81.7%
Free Cash Flow

-$33.3M

Previous: -$77.1M+56.8%
Net Income

-$51.9M

Previous: -$218M+76.2%
Operating Income

-$50.9M

Previous: -$171M+70.2%
Cash & Equivalents

$76.1M

Previous: $82.5M-7.8%
Total Assets

$142M

No prior period
Stock-Based Comp

$13M

Previous: $29.5M-56.0%

Revenue & EPS history

Biohaven · Revenue · Quarterly

$190M

Q4 2021+441.1%vs Q4 2020
Beat estimate in 8 of 9 quarters(89%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 14 quarterly earnings reports

Historical avg

-0.5%

Avg return

Earnings day

+2.0%

Avg return

5 days after

+7.7%

Avg return

30 days after

50%

7 / 14 earnings

Positive

+12.6%

Q2 2024

Best reaction

-12.5%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025-9.7%-16.0%-17.0%
Q3 2024-6.5%+0.5%+28.3%
Q3 2025-5.7%+0.5%+28.3%
Q2 2025-9.0%+6.6%-5.0%
Q1 2025+0.0%-3.7%-5.2%
Q4 2024-2.2%-7.1%-36.3%
Q2 2024+12.6%+13.7%+6.7%
Q1 2024-12.5%-8.7%-17.5%
Q4 2023+4.7%+24.0%+15.6%
Q3 2023+1.0%+4.6%+30.9%
Q2 2023+3.1%+3.4%-3.3%
Q1 2023+5.3%+2.2%+72.6%
Q4 2022+10.4%+5.4%+10.8%
Q3 2022+1.2%+2.2%-0.9%
Q2 2022———
Q1 2022———
Q4 2021———
Q3 2021———
Q2 2021———
Q1 2021———
Q4 2020———
Q3 2020———
Q2 2020———
Q1 2020———
Q4 2019———
Q3 2019———
Q2 2019———
Q1 2019———
Q4 2018———
Q3 2018———
Q2 2018———
Q1 2018———
Q4 2017———
Q3 2017———
Q2 2017———
Q1 2017———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro